CytoSorbents (NASDAQ:CTSO) reported its Q1 earnings results on Tuesday, May 3, 2022 at 04:15 PM.
Here’s what investors need to know about the announcement.
Earnings
CytoSorbents missed estimated earnings by 75.0%, reporting an EPS of $-0.21 versus an estimate of $-0.12.
Revenue was down $1.91 million from the same period last year.
Past Earnings Performance
Last quarter the company missed on EPS by $0.08 which was followed by a 4.27% drop in the share price the next day.
Here’s a look at CytoSorbents’s past performance:
| Quarter | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
|---|---|---|---|---|
| EPS Estimate | -0.13 | -0.12 | -0.04 | -0.03 |
| EPS Actual | -0.21 | -0.15 | -0.11 | -0.10 |
| Revenue Estimate | 10.11M | 11.02M | 12.27M | 11.50M |
| Revenue Actual | 10.78M | 9.76M | 12.02M | 10.60M |
To track all earnings releases for CytoSorbents visit their earnings calendar here.
This article was generated by Benzinga’s automated content engine and reviewed by an editor.
